Num | GO | Overlap | Size | P Value | Adj. P Value |
1 |
TISSUE DEVELOPMENT |
26 |
1518 |
8.14e-12 |
3.787e-08 |
2 |
RESPONSE TO ESTRADIOL |
10 |
146 |
1.321e-10 |
2.049e-07 |
3 |
REGULATION OF PROTEIN MODIFICATION PROCESS |
26 |
1710 |
1.155e-10 |
2.049e-07 |
4 |
EPITHELIUM DEVELOPMENT |
19 |
945 |
7.699e-10 |
7.408e-07 |
5 |
REGULATION OF MAPK CASCADE |
16 |
660 |
1.514e-09 |
7.408e-07 |
6 |
NEGATIVE REGULATION OF KINASE ACTIVITY |
11 |
250 |
1.679e-09 |
7.408e-07 |
7 |
OSSIFICATION |
11 |
251 |
1.751e-09 |
7.408e-07 |
8 |
UROGENITAL SYSTEM DEVELOPMENT |
12 |
299 |
8.155e-10 |
7.408e-07 |
9 |
GLAND DEVELOPMENT |
13 |
395 |
1.688e-09 |
7.408e-07 |
10 |
REGULATION OF PHOSPHORUS METABOLIC PROCESS |
24 |
1618 |
1.271e-09 |
7.408e-07 |
11 |
REGULATION OF CELL PROLIFERATION |
23 |
1496 |
1.581e-09 |
7.408e-07 |
12 |
POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
20 |
1135 |
2.452e-09 |
9.509e-07 |
13 |
NEGATIVE REGULATION OF MAPK CASCADE |
9 |
145 |
2.821e-09 |
1.01e-06 |
14 |
TISSUE MORPHOGENESIS |
14 |
533 |
6.721e-09 |
1.646e-06 |
15 |
REGULATION OF TRANSFERASE ACTIVITY |
18 |
946 |
5.603e-09 |
1.646e-06 |
16 |
NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
13 |
437 |
5.685e-09 |
1.646e-06 |
17 |
ORGAN MORPHOGENESIS |
17 |
841 |
6.606e-09 |
1.646e-06 |
18 |
RESPONSE TO ESTROGEN |
10 |
218 |
6.574e-09 |
1.646e-06 |
19 |
NEGATIVE REGULATION OF CELL COMMUNICATION |
20 |
1192 |
5.663e-09 |
1.646e-06 |
20 |
POSITIVE REGULATION OF RESPONSE TO STIMULUS |
25 |
1929 |
8.204e-09 |
1.907e-06 |
21 |
POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS |
22 |
1492 |
8.606e-09 |
1.907e-06 |
22 |
NEGATIVE REGULATION OF RESPONSE TO STIMULUS |
21 |
1360 |
9.256e-09 |
1.958e-06 |
23 |
TUBE DEVELOPMENT |
14 |
552 |
1.047e-08 |
2.118e-06 |
24 |
HEART DEVELOPMENT |
13 |
466 |
1.221e-08 |
2.367e-06 |
25 |
REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT |
23 |
1672 |
1.321e-08 |
2.418e-06 |
26 |
REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
13 |
470 |
1.351e-08 |
2.418e-06 |
27 |
CELLULAR GLUCURONIDATION |
5 |
22 |
1.414e-08 |
2.437e-06 |
28 |
REGULATION OF KINASE ACTIVITY |
16 |
776 |
1.508e-08 |
2.505e-06 |
29 |
INOSITOL LIPID MEDIATED SIGNALING |
8 |
124 |
1.668e-08 |
2.676e-06 |
30 |
POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
18 |
1036 |
2.285e-08 |
3.43e-06 |
31 |
POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
18 |
1036 |
2.285e-08 |
3.43e-06 |
32 |
TUBE MORPHOGENESIS |
11 |
323 |
2.4e-08 |
3.49e-06 |
33 |
BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE |
8 |
131 |
2.568e-08 |
3.622e-06 |
34 |
PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
5 |
25 |
2.829e-08 |
3.872e-06 |
35 |
POSITIVE REGULATION OF CELL PROLIFERATION |
16 |
814 |
2.938e-08 |
3.906e-06 |
36 |
NEGATIVE REGULATION OF PHOSPHORYLATION |
12 |
422 |
3.832e-08 |
4.953e-06 |
37 |
GLUCURONATE METABOLIC PROCESS |
5 |
27 |
4.274e-08 |
5.234e-06 |
38 |
URONIC ACID METABOLIC PROCESS |
5 |
27 |
4.274e-08 |
5.234e-06 |
39 |
NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS |
18 |
1087 |
4.757e-08 |
5.676e-06 |
40 |
FLAVONOID METABOLIC PROCESS |
5 |
28 |
5.189e-08 |
6.036e-06 |
41 |
NEGATIVE REGULATION OF TRANSFERASE ACTIVITY |
11 |
351 |
5.605e-08 |
6.36e-06 |
42 |
PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS |
24 |
1977 |
6.429e-08 |
7.122e-06 |
43 |
CELL PROLIFERATION |
14 |
672 |
1.208e-07 |
1.278e-05 |
44 |
REGULATION OF MITOTIC CELL CYCLE |
12 |
468 |
1.181e-07 |
1.278e-05 |
45 |
CARDIOVASCULAR SYSTEM DEVELOPMENT |
15 |
788 |
1.294e-07 |
1.309e-05 |
46 |
CIRCULATORY SYSTEM DEVELOPMENT |
15 |
788 |
1.294e-07 |
1.309e-05 |
47 |
MESODERM MORPHOGENESIS |
6 |
66 |
1.465e-07 |
1.451e-05 |
48 |
FORMATION OF PRIMARY GERM LAYER |
7 |
110 |
1.517e-07 |
1.471e-05 |
49 |
INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
4 |
14 |
1.59e-07 |
1.51e-05 |
50 |
ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY |
14 |
689 |
1.64e-07 |
1.526e-05 |
51 |
MORPHOGENESIS OF A BRANCHING STRUCTURE |
8 |
167 |
1.693e-07 |
1.545e-05 |
52 |
MORPHOGENESIS OF AN EPITHELIUM |
11 |
400 |
2.09e-07 |
1.87e-05 |
53 |
RESPONSE TO STEROID HORMONE |
12 |
497 |
2.256e-07 |
1.944e-05 |
54 |
PROTEIN PHOSPHORYLATION |
16 |
944 |
2.238e-07 |
1.944e-05 |
55 |
MAMMARY GLAND DEVELOPMENT |
7 |
117 |
2.317e-07 |
1.96e-05 |
56 |
REGULATION OF CELL CYCLE |
16 |
949 |
2.403e-07 |
1.965e-05 |
57 |
DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION |
13 |
602 |
2.408e-07 |
1.965e-05 |
58 |
REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
21 |
1656 |
2.715e-07 |
2.178e-05 |
59 |
KIDNEY EPITHELIUM DEVELOPMENT |
7 |
125 |
3.64e-07 |
2.871e-05 |
60 |
POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS |
4 |
17 |
3.75e-07 |
2.884e-05 |
61 |
PROSTATE GLAND DEVELOPMENT |
5 |
41 |
3.813e-07 |
2.884e-05 |
62 |
NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
7 |
126 |
3.843e-07 |
2.884e-05 |
63 |
RENAL TUBULE DEVELOPMENT |
6 |
78 |
4.002e-07 |
2.956e-05 |
64 |
REGULATION OF GROWTH |
13 |
633 |
4.262e-07 |
3.099e-05 |
65 |
BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS |
5 |
44 |
5.479e-07 |
3.7e-05 |
66 |
NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
12 |
541 |
5.566e-07 |
3.7e-05 |
67 |
EMBRYONIC MORPHOGENESIS |
12 |
539 |
5.352e-07 |
3.7e-05 |
68 |
KIDNEY MORPHOGENESIS |
6 |
82 |
5.394e-07 |
3.7e-05 |
69 |
CELL DEVELOPMENT |
19 |
1426 |
5.561e-07 |
3.7e-05 |
70 |
NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
12 |
541 |
5.566e-07 |
3.7e-05 |
71 |
EMBRYO DEVELOPMENT |
15 |
894 |
6.484e-07 |
4.133e-05 |
72 |
GLIAL CELL DIFFERENTIATION |
7 |
136 |
6.454e-07 |
4.133e-05 |
73 |
REGULATION OF CELLULAR COMPONENT MOVEMENT |
14 |
771 |
6.368e-07 |
4.133e-05 |
74 |
SKELETAL SYSTEM DEVELOPMENT |
11 |
455 |
7.487e-07 |
4.668e-05 |
75 |
RESPONSE TO ALCOHOL |
10 |
362 |
7.524e-07 |
4.668e-05 |
76 |
ANTERIOR POSTERIOR AXIS SPECIFICATION |
5 |
48 |
8.542e-07 |
5.23e-05 |
77 |
RESPONSE TO ORGANIC CYCLIC COMPOUND |
15 |
917 |
8.924e-07 |
5.392e-05 |
78 |
REGULATION OF EPITHELIAL CELL PROLIFERATION |
9 |
285 |
9.338e-07 |
5.521e-05 |
79 |
MESONEPHROS DEVELOPMENT |
6 |
90 |
9.373e-07 |
5.521e-05 |
80 |
REGULATION OF CELL DIFFERENTIATION |
19 |
1492 |
1.103e-06 |
6.417e-05 |
81 |
POSITIVE REGULATION OF BIOSYNTHETIC PROCESS |
21 |
1805 |
1.124e-06 |
6.455e-05 |
82 |
NEPHRON EPITHELIUM DEVELOPMENT |
6 |
93 |
1.138e-06 |
6.455e-05 |
83 |
NEGATIVE REGULATION OF MOLECULAR FUNCTION |
16 |
1079 |
1.325e-06 |
7.427e-05 |
84 |
MAMMARY GLAND EPITHELIUM DEVELOPMENT |
5 |
53 |
1.411e-06 |
7.726e-05 |
85 |
MESONEPHRIC TUBULE MORPHOGENESIS |
5 |
53 |
1.411e-06 |
7.726e-05 |
86 |
POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
7 |
154 |
1.49e-06 |
7.986e-05 |
87 |
PHOSPHORYLATION |
17 |
1228 |
1.493e-06 |
7.986e-05 |
88 |
GASTRULATION |
7 |
155 |
1.556e-06 |
8.227e-05 |
89 |
POSITIVE REGULATION OF CELL COMMUNICATION |
19 |
1532 |
1.64e-06 |
8.479e-05 |
90 |
BONE DEVELOPMENT |
7 |
156 |
1.624e-06 |
8.479e-05 |
91 |
TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY |
11 |
498 |
1.805e-06 |
9.23e-05 |
92 |
NEGATIVE REGULATION OF CELL DIFFERENTIATION |
12 |
609 |
1.923e-06 |
9.726e-05 |
93 |
REGULATION OF CATABOLIC PROCESS |
13 |
731 |
2.13e-06 |
0.0001066 |
94 |
NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
12 |
616 |
2.165e-06 |
0.0001071 |
95 |
REPRODUCTIVE SYSTEM DEVELOPMENT |
10 |
408 |
2.21e-06 |
0.0001082 |
96 |
MESODERMAL CELL DIFFERENTIATION |
4 |
26 |
2.298e-06 |
0.0001114 |
97 |
INTRACELLULAR SIGNAL TRANSDUCTION |
19 |
1572 |
2.406e-06 |
0.0001154 |
98 |
REGULATION OF GLUCOSE IMPORT |
5 |
60 |
2.633e-06 |
0.000125 |
99 |
REGULATION OF CELL ADHESION |
12 |
629 |
2.685e-06 |
0.0001262 |
100 |
NEGATIVE REGULATION OF CELL DEATH |
14 |
872 |
2.718e-06 |
0.0001265 |
101 |
REPRODUCTION |
17 |
1297 |
3.141e-06 |
0.0001447 |
102 |
POSITIVE REGULATION OF CELL CYCLE |
9 |
332 |
3.279e-06 |
0.0001496 |
103 |
RESPONSE TO LIPID |
14 |
888 |
3.356e-06 |
0.0001507 |
104 |
NEGATIVE REGULATION OF CELL PROLIFERATION |
12 |
643 |
3.367e-06 |
0.0001507 |
105 |
GLIOGENESIS |
7 |
175 |
3.489e-06 |
0.0001546 |
106 |
RESPONSE TO HORMONE |
14 |
893 |
3.582e-06 |
0.0001572 |
107 |
NEPHRON DEVELOPMENT |
6 |
115 |
3.942e-06 |
0.0001714 |
108 |
POSITIVE REGULATION OF MOLECULAR FUNCTION |
20 |
1791 |
4.103e-06 |
0.0001768 |
109 |
RESPONSE TO EXTRACELLULAR STIMULUS |
10 |
441 |
4.409e-06 |
0.0001882 |
110 |
MESODERM DEVELOPMENT |
6 |
118 |
4.577e-06 |
0.0001936 |
111 |
CELLULAR RESPONSE TO HORMONE STIMULUS |
11 |
552 |
4.847e-06 |
0.0002032 |
112 |
PERIPHERAL NERVOUS SYSTEM DEVELOPMENT |
5 |
69 |
5.283e-06 |
0.0002195 |
113 |
REGULATION OF CELL CYCLE PROCESS |
11 |
558 |
5.372e-06 |
0.0002212 |
114 |
REGULATION OF EPITHELIAL CELL DIFFERENTIATION |
6 |
122 |
5.551e-06 |
0.0002246 |
115 |
REGULATION OF CELLULAR AMIDE METABOLIC PROCESS |
9 |
354 |
5.518e-06 |
0.0002246 |
116 |
POSITIVE REGULATION OF MITOTIC CELL CYCLE |
6 |
123 |
5.819e-06 |
0.0002314 |
117 |
NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS |
13 |
801 |
5.78e-06 |
0.0002314 |
118 |
PROTEIN DEPHOSPHORYLATION |
7 |
190 |
6e-06 |
0.0002366 |
119 |
RESPONSE TO NUTRIENT |
7 |
191 |
6.21e-06 |
0.0002428 |
120 |
CELLULAR RESPONSE TO ORGANIC SUBSTANCE |
20 |
1848 |
6.595e-06 |
0.0002557 |
121 |
NEGATIVE REGULATION OF MAP KINASE ACTIVITY |
5 |
73 |
6.981e-06 |
0.0002662 |
122 |
PROTEIN KINASE B SIGNALING |
4 |
34 |
6.972e-06 |
0.0002662 |
123 |
REGULATION OF REPRODUCTIVE PROCESS |
6 |
129 |
7.656e-06 |
0.0002896 |
124 |
REGULATION OF GLYCOGEN METABOLIC PROCESS |
4 |
35 |
7.85e-06 |
0.0002945 |
125 |
ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS |
14 |
957 |
7.924e-06 |
0.000295 |
126 |
NEGATIVE REGULATION OF CATALYTIC ACTIVITY |
13 |
829 |
8.367e-06 |
0.000309 |
127 |
NEUROGENESIS |
17 |
1402 |
8.874e-06 |
0.0003226 |
128 |
POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS |
4 |
36 |
8.806e-06 |
0.0003226 |
129 |
MONOSACCHARIDE METABOLIC PROCESS |
7 |
202 |
8.958e-06 |
0.0003231 |
130 |
POSITIVE REGULATION OF GENE EXPRESSION |
19 |
1733 |
9.96e-06 |
0.000356 |
131 |
MAMMARY GLAND EPITHELIAL CELL PROLIFERATION |
3 |
12 |
1.002e-05 |
0.000356 |
132 |
GERM CELL DEVELOPMENT |
7 |
209 |
1.118e-05 |
0.0003942 |
133 |
REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
6 |
138 |
1.127e-05 |
0.0003943 |
134 |
METANEPHROS DEVELOPMENT |
5 |
81 |
1.164e-05 |
0.0004042 |
135 |
HEART MORPHOGENESIS |
7 |
212 |
1.227e-05 |
0.0004228 |
136 |
NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION |
5 |
82 |
1.236e-05 |
0.0004229 |
137 |
MULTI MULTICELLULAR ORGANISM PROCESS |
7 |
213 |
1.265e-05 |
0.0004295 |
138 |
POSITIVE REGULATION OF CATABOLIC PROCESS |
9 |
395 |
1.328e-05 |
0.0004477 |
139 |
MAMMARY GLAND MORPHOGENESIS |
4 |
40 |
1.351e-05 |
0.0004524 |
140 |
POSITIVE REGULATION OF TRANSFERASE ACTIVITY |
11 |
616 |
1.361e-05 |
0.0004524 |
141 |
RESPONSE TO ENDOGENOUS STIMULUS |
17 |
1450 |
1.38e-05 |
0.0004553 |
142 |
CELLULAR RESPONSE TO ENDOGENOUS STIMULUS |
14 |
1008 |
1.425e-05 |
0.0004667 |
143 |
CENTRAL NERVOUS SYSTEM DEVELOPMENT |
13 |
872 |
1.434e-05 |
0.0004667 |
144 |
CELLULAR RESPONSE TO ESTROGEN STIMULUS |
4 |
41 |
1.493e-05 |
0.0004825 |
145 |
POSITIVE REGULATION OF GLUCOSE TRANSPORT |
4 |
42 |
1.646e-05 |
0.0005243 |
146 |
REGULATION OF CELL DEATH |
17 |
1472 |
1.678e-05 |
0.0005243 |
147 |
RESPONSE TO TRANSITION METAL NANOPARTICLE |
6 |
148 |
1.679e-05 |
0.0005243 |
148 |
BONE MATURATION |
3 |
14 |
1.65e-05 |
0.0005243 |
149 |
MALE SEX DIFFERENTIATION |
6 |
148 |
1.679e-05 |
0.0005243 |
150 |
NEURAL TUBE DEVELOPMENT |
6 |
149 |
1.744e-05 |
0.0005411 |
151 |
MULTI ORGANISM REPRODUCTIVE PROCESS |
13 |
891 |
1.801e-05 |
0.000554 |
152 |
REGULATION OF POLYSACCHARIDE METABOLIC PROCESS |
4 |
43 |
1.81e-05 |
0.000554 |
153 |
AXIS SPECIFICATION |
5 |
90 |
1.947e-05 |
0.000592 |
154 |
REGULATION OF MAP KINASE ACTIVITY |
8 |
319 |
2.096e-05 |
0.0006334 |
155 |
NEGATIVE REGULATION OF GROWTH |
7 |
236 |
2.45e-05 |
0.0007353 |
156 |
POSITIVE REGULATION OF CATALYTIC ACTIVITY |
17 |
1518 |
2.496e-05 |
0.0007446 |
157 |
GLAND MORPHOGENESIS |
5 |
97 |
2.799e-05 |
0.0008288 |
158 |
POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION |
4 |
48 |
2.814e-05 |
0.0008288 |
159 |
DEVELOPMENTAL GROWTH |
8 |
333 |
2.849e-05 |
0.0008337 |
160 |
REGULATION OF NUCLEAR DIVISION |
6 |
163 |
2.898e-05 |
0.0008427 |
161 |
NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA |
3 |
17 |
3.058e-05 |
0.0008838 |
162 |
REGULATION OF EPITHELIAL CELL MIGRATION |
6 |
166 |
3.21e-05 |
0.0009142 |
163 |
REGULATION OF GLUCOSE TRANSPORT |
5 |
100 |
3.242e-05 |
0.0009142 |
164 |
POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
5 |
100 |
3.242e-05 |
0.0009142 |
165 |
PEPTIDYL TYROSINE DEPHOSPHORYLATION |
5 |
100 |
3.242e-05 |
0.0009142 |
166 |
POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION |
4 |
51 |
3.585e-05 |
0.0009988 |
167 |
POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION |
9 |
448 |
3.575e-05 |
0.0009988 |
168 |
RESPONSE TO WOUNDING |
10 |
563 |
3.642e-05 |
0.001008 |
169 |
ORGAN MATURATION |
3 |
18 |
3.66e-05 |
0.001008 |
170 |
CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM |
7 |
252 |
3.723e-05 |
0.001013 |
171 |
REGULATION OF NEURON DEATH |
7 |
252 |
3.723e-05 |
0.001013 |
172 |
NEGATIVE REGULATION OF NEURON DEATH |
6 |
171 |
3.792e-05 |
0.001026 |
173 |
REGULATION OF GLUCOSE METABOLIC PROCESS |
5 |
106 |
4.29e-05 |
0.001154 |
174 |
RESPONSE TO CORTICOSTEROID |
6 |
176 |
4.455e-05 |
0.001191 |
175 |
REGULATION OF CELL DEVELOPMENT |
12 |
836 |
4.619e-05 |
0.001228 |
176 |
CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND |
9 |
465 |
4.772e-05 |
0.001262 |
177 |
BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS |
3 |
20 |
5.086e-05 |
0.001337 |
178 |
WOUND HEALING |
9 |
470 |
5.183e-05 |
0.001354 |
179 |
REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS |
6 |
181 |
5.208e-05 |
0.001354 |
180 |
SEX DIFFERENTIATION |
7 |
266 |
5.244e-05 |
0.001356 |
181 |
NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY |
3 |
21 |
5.919e-05 |
0.001521 |
182 |
RESPONSE TO NITROGEN COMPOUND |
12 |
859 |
5.999e-05 |
0.001534 |
183 |
REGULATION OF CELL DIVISION |
7 |
272 |
6.036e-05 |
0.001535 |
184 |
POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
14 |
1152 |
6.195e-05 |
0.001566 |
185 |
REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS |
7 |
274 |
6.32e-05 |
0.00159 |
186 |
POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS |
12 |
867 |
6.557e-05 |
0.00164 |
187 |
STEM CELL PROLIFERATION |
4 |
60 |
6.824e-05 |
0.001689 |
188 |
REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION |
4 |
60 |
6.824e-05 |
0.001689 |
189 |
DEVELOPMENTAL MATURATION |
6 |
193 |
7.435e-05 |
0.00183 |
190 |
POSITIVE REGULATION OF NUCLEAR DIVISION |
4 |
62 |
7.763e-05 |
0.001891 |
191 |
REGULATION OF BINDING |
7 |
283 |
7.74e-05 |
0.001891 |
192 |
DEPHOSPHORYLATION |
7 |
286 |
8.268e-05 |
0.002004 |
193 |
NEGATIVE REGULATION OF WNT SIGNALING PATHWAY |
6 |
197 |
8.326e-05 |
0.002007 |
194 |
REGULATION OF PROTEIN CATABOLIC PROCESS |
8 |
393 |
9.128e-05 |
0.002189 |
195 |
POSITIVE REGULATION OF BINDING |
5 |
127 |
0.0001014 |
0.00242 |
196 |
NEGATIVE REGULATION OF HEMOPOIESIS |
5 |
128 |
0.0001053 |
0.002499 |
197 |
SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION |
8 |
404 |
0.0001105 |
0.002609 |
198 |
ORGAN GROWTH |
4 |
68 |
0.0001115 |
0.00262 |
199 |
INACTIVATION OF MAPK ACTIVITY |
3 |
26 |
0.0001142 |
0.00267 |
200 |
RESPONSE TO OXYGEN CONTAINING COMPOUND |
15 |
1381 |
0.0001159 |
0.002696 |
201 |
NEGATIVE REGULATION OF CELL DEVELOPMENT |
7 |
303 |
0.0001184 |
0.002741 |
202 |
POSITIVE REGULATION OF CELL DIVISION |
5 |
132 |
0.0001217 |
0.002803 |
203 |
GROWTH |
8 |
410 |
0.0001223 |
0.002803 |
204 |
REGULATION OF WNT SIGNALING PATHWAY |
7 |
310 |
0.0001364 |
0.003111 |
205 |
REGULATION OF IMMUNE SYSTEM PROCESS |
15 |
1403 |
0.0001381 |
0.00312 |
206 |
DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS |
6 |
216 |
0.0001379 |
0.00312 |
207 |
RESPONSE TO ETHANOL |
5 |
136 |
0.00014 |
0.003147 |
208 |
MAMMARY GLAND DUCT MORPHOGENESIS |
3 |
28 |
0.0001431 |
0.003202 |
209 |
POSITIVE REGULATION OF LOCOMOTION |
8 |
420 |
0.0001443 |
0.003212 |
210 |
CELLULAR RESPONSE TO STEROID HORMONE STIMULUS |
6 |
218 |
0.000145 |
0.003214 |
211 |
EMBRYONIC HINDLIMB MORPHOGENESIS |
3 |
29 |
0.0001592 |
0.003495 |
212 |
REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY |
3 |
29 |
0.0001592 |
0.003495 |
213 |
POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS |
4 |
75 |
0.0001632 |
0.003565 |
214 |
REGULATION OF CELL CYCLE PHASE TRANSITION |
7 |
321 |
0.0001691 |
0.003676 |
215 |
GLIAL CELL DEVELOPMENT |
4 |
76 |
0.0001718 |
0.003718 |
216 |
POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION |
3 |
30 |
0.0001765 |
0.003784 |
217 |
CELLULAR RESPONSE TO ESTRADIOL STIMULUS |
3 |
30 |
0.0001765 |
0.003784 |
218 |
EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING |
9 |
554 |
0.0001805 |
0.003821 |
219 |
REGULATION OF NEURON DIFFERENTIATION |
9 |
554 |
0.0001805 |
0.003821 |
220 |
CELL FATE COMMITMENT |
6 |
227 |
0.0001807 |
0.003821 |
221 |
CELLULAR RESPONSE TO INSULIN STIMULUS |
5 |
146 |
0.0001951 |
0.004088 |
222 |
SCHWANN CELL DIFFERENTIATION |
3 |
31 |
0.0001949 |
0.004088 |
223 |
REGULATION OF LEUKOCYTE DIFFERENTIATION |
6 |
232 |
0.0002033 |
0.004242 |
224 |
REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS |
5 |
148 |
0.0002078 |
0.004275 |
225 |
DIGESTIVE SYSTEM DEVELOPMENT |
5 |
148 |
0.0002078 |
0.004275 |
226 |
POSITIVE REGULATION OF CELL GROWTH |
5 |
148 |
0.0002078 |
0.004275 |
227 |
INSULIN RECEPTOR SIGNALING PATHWAY |
4 |
80 |
0.0002095 |
0.004275 |
228 |
CELLULAR RESPONSE TO MECHANICAL STIMULUS |
4 |
80 |
0.0002095 |
0.004275 |
229 |
RESPONSE TO METAL ION |
7 |
333 |
0.0002116 |
0.0043 |
230 |
REGULATION OF TRANSPORT |
17 |
1804 |
0.0002128 |
0.004305 |
231 |
ENDOCARDIAL CUSHION DEVELOPMENT |
3 |
32 |
0.0002144 |
0.00432 |
232 |
POSITIVE REGULATION OF DEVELOPMENTAL PROCESS |
13 |
1142 |
0.0002249 |
0.00451 |
233 |
MUSCLE CELL DIFFERENTIATION |
6 |
237 |
0.0002281 |
0.004554 |
234 |
EMBRYONIC AXIS SPECIFICATION |
3 |
33 |
0.0002353 |
0.004619 |
235 |
REGULATION OF MYELINATION |
3 |
33 |
0.0002353 |
0.004619 |
236 |
REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS |
5 |
152 |
0.0002352 |
0.004619 |
237 |
POSITIVE REGULATION OF GROWTH |
6 |
238 |
0.0002333 |
0.004619 |
238 |
REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY |
5 |
153 |
0.0002425 |
0.004741 |
239 |
NEGATIVE REGULATION OF TRANSPORT |
8 |
458 |
0.0002599 |
0.005059 |
240 |
POSITIVE REGULATION OF DNA REPLICATION |
4 |
86 |
0.0002767 |
0.005364 |
241 |
NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS |
3 |
35 |
0.0002808 |
0.005398 |
242 |
NEGATIVE REGULATION OF CELLULAR RESPONSE TO OXIDATIVE STRESS |
3 |
35 |
0.0002808 |
0.005398 |
243 |
REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS |
4 |
87 |
0.0002892 |
0.005538 |
244 |
WNT SIGNALING PATHWAY |
7 |
351 |
0.0002914 |
0.005557 |
245 |
REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS |
12 |
1021 |
0.0003024 |
0.005743 |
246 |
POSITIVE REGULATION OF MAPK CASCADE |
8 |
470 |
0.0003092 |
0.005848 |
247 |
SEGMENTATION |
4 |
89 |
0.0003155 |
0.005895 |
248 |
REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY |
4 |
89 |
0.0003155 |
0.005895 |
249 |
EPITHELIAL CELL PROLIFERATION |
4 |
89 |
0.0003155 |
0.005895 |
250 |
POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
11 |
876 |
0.0003169 |
0.005898 |
251 |
NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY |
4 |
90 |
0.0003293 |
0.006104 |
252 |
HINDLIMB MORPHOGENESIS |
3 |
37 |
0.0003316 |
0.006122 |
253 |
ENSHEATHMENT OF NEURONS |
4 |
91 |
0.0003434 |
0.006292 |
254 |
AXON ENSHEATHMENT |
4 |
91 |
0.0003434 |
0.006292 |
255 |
REGULATION OF HORMONE LEVELS |
8 |
478 |
0.0003461 |
0.006316 |
256 |
RESPONSE TO INORGANIC SUBSTANCE |
8 |
479 |
0.000351 |
0.006379 |
257 |
REGULATION OF APOPTOTIC SIGNALING PATHWAY |
7 |
363 |
0.0003569 |
0.006461 |
258 |
RESPONSE TO TESTOSTERONE |
3 |
38 |
0.0003591 |
0.006475 |
259 |
POSITIVE REGULATION OF KINASE ACTIVITY |
8 |
482 |
0.0003659 |
0.006573 |
260 |
REGULATION OF DNA BINDING |
4 |
93 |
0.0003731 |
0.006678 |
261 |
REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
10 |
750 |
0.0003802 |
0.006778 |
262 |
ERBB2 SIGNALING PATHWAY |
3 |
39 |
0.000388 |
0.006824 |
263 |
ANATOMICAL STRUCTURE MATURATION |
3 |
39 |
0.000388 |
0.006824 |
264 |
NEURAL TUBE FORMATION |
4 |
94 |
0.0003887 |
0.006824 |
265 |
NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION |
3 |
39 |
0.000388 |
0.006824 |
266 |
POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS |
6 |
263 |
0.0003979 |
0.00696 |
267 |
CELLULAR RESPONSE TO EXTERNAL STIMULUS |
6 |
264 |
0.000406 |
0.007075 |
268 |
REGULATION OF CARBOHYDRATE METABOLIC PROCESS |
5 |
172 |
0.0004157 |
0.007218 |
269 |
SENSORY ORGAN DEVELOPMENT |
8 |
493 |
0.0004251 |
0.007353 |
270 |
STRIATED MUSCLE CELL DIFFERENTIATION |
5 |
173 |
0.0004269 |
0.007357 |
271 |
CELL SUBSTRATE JUNCTION ASSEMBLY |
3 |
41 |
0.0004502 |
0.007729 |
272 |
RESPONSE TO VITAMIN |
4 |
98 |
0.0004554 |
0.00779 |
273 |
MULTICELLULAR ORGANISM REPRODUCTION |
10 |
768 |
0.000458 |
0.007807 |
274 |
POSITIVE REGULATION OF DNA BINDING |
3 |
42 |
0.0004835 |
0.008211 |
275 |
MODIFICATION OF MORPHOLOGY OR PHYSIOLOGY OF OTHER ORGANISM |
4 |
100 |
0.0004916 |
0.008258 |
276 |
REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION |
4 |
100 |
0.0004916 |
0.008258 |
277 |
LIMBIC SYSTEM DEVELOPMENT |
4 |
100 |
0.0004916 |
0.008258 |
278 |
REGULATION OF GLYCOPROTEIN METABOLIC PROCESS |
3 |
43 |
0.0005184 |
0.008677 |
279 |
RESPONSE TO KETONE |
5 |
182 |
0.0005379 |
0.00897 |
280 |
REGULATION OF CELL GROWTH |
7 |
391 |
0.0005561 |
0.009111 |
281 |
NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION |
3 |
44 |
0.0005549 |
0.009111 |
282 |
REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA |
3 |
44 |
0.0005549 |
0.009111 |
283 |
POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION |
4 |
103 |
0.0005497 |
0.009111 |
284 |
POSITIVE REGULATION OF TRANSPORT |
11 |
936 |
0.000554 |
0.009111 |
285 |
BEHAVIOR |
8 |
516 |
0.0005742 |
0.009374 |
286 |
POSITIVE REGULATION OF DNA METABOLIC PROCESS |
5 |
185 |
0.0005793 |
0.009425 |
287 |
RESPONSE TO XENOBIOTIC STIMULUS |
4 |
105 |
0.0005911 |
0.009515 |
288 |
MODIFICATION BY SYMBIONT OF HOST MORPHOLOGY OR PHYSIOLOGY |
3 |
45 |
0.000593 |
0.009515 |
289 |
SYSTEM PROCESS |
16 |
1785 |
0.0005922 |
0.009515 |
290 |
HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES |
3 |
45 |
0.000593 |
0.009515 |